Form 4 for TNDM TANDEM DIABETES CARE INC
Accepted 2022-05-18 00:00:00 ET · period of report 2022-05-16 · accession 0001438133-22-000083 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-18 | 2022-05-16 | TNDM | Vosseller Leigh | EVP, CFO | M - OptEx | $0.00 | +650 | 7,268 | +10% | $0 |
| D | 2022-05-18 | 2022-05-16 | TNDM | Vosseller Leigh | EVP, CFO | F - Tax | $73.85 | -225 | 7,043 | -3% | -$16.6K |
| D | 2022-05-18 | 2022-05-16 | TNDM | Vosseller Leigh | EVP, CFO | A - Grant | $61.17 | +306 | 7,349 | +4% | +$18.7K |
| D | 2022-05-18 | 2022-05-16 | TNDM | Vosseller Leigh | EVP, CFO | M - OptEx | $0.00 | +650 | 1,949 | +50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-16 | M | A | 650 | $0.00 | 7,268 | D | — | — | |
| 2 | Common | Common Stock | 2022-05-16 | F | D | 225 | $73.85 | 7,043 | D | — | — | |
| 3 | Common | Common Stock | 2022-05-16 | A | A | 306 | $61.17 | 7,349 | D | — | — | (F2) The reporting person is voluntarily reporting the acquisition of shares of common stock pursuant to the Tandem Diabetes Care, Inc. Amended and Restated 2013 Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 16, 2021 through May 16, 2022. This transaction is also exempt under Rule 16b-3(c). |
| 4 | Derivative | Restricted Stock Unit | 2022-05-16 | M | A | 650 | $0.00 | 1,949 | D | — · — to — | 650 Common Stock | (F4) Granted pursuant to the Tandem Diabetes Care, Inc. 2013 Stock Incentive Plan (the 2013 Plan). (F5) Each RSU represents a contingent right to receive one share of common stock of the Company. (F6) RSU vest as to twenty-five percent (25%) of the total number of shares subject to the RSU on 5/15/2022, and the remaining shares shall vest in twelve (12) equal quarterly installments thereafter. |